ASMB
Assembly Biosciences Inc
23.70$
+0.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
Assembly Biosciences Inc (ASMB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -41 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.1 | -3.5 | -5.2 | -25 | -21 | -18 | -15 | -19 | -35 | 1.9 | -65 | -84 | -63 | -93 | -84 | 23 | -51 | -41 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.2 | 0.6 | 0.5 | 0.7 | 0.5 | 0.5 | 0.5 | 0.1 | 0.1 | |
| 0.5 | 0.1 | 2.4 | 3.0 | 3.2 | 1.7 | 11 | 7.9 | 5.0 | 8.6 | 28 | 21 | 22 | 5.2 | 6.6 | 5.1 | 3.1 | 4.7 | |
| – | – | – | 3.0 | 2.8 | 1.7 | 11 | 7.9 | 5.5 | 0.2 | 30 | 24 | 29 | 47 | 10 | – | – | – | |
| 2.6 | 0.0 | -3.1 | 2.0 | 0.2 | -0.1 | -2.5 | 1.8 | 3.8 | 44 | -4.2 | -9.5 | -30 | -11 | -2.1 | 76 | -12 | -38 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.9 | 0.3 | 1.6 | 2.2 | 3.1 | 0.1 | 0.3 | 0.0 | 0.1 | |
| 0.0 | 0.0 | – | 0.0 | 0.0 | 0.0 | 0.3 | -65 | 36 | -16 | -135 | -50 | 68 | 27 | 91 | -69 | 40 | -113 | |
| – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | |
| – | – | – | 50 | 4.2 | 24 | 17 | 82 | 0.2 | 67 | 160 | 140 | 7.6 | – | 0.6 | – | – | – | |
| – | – | – | 0.4 | 0.5 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 2.5 | 3.6 | 20 | 47 | 4.9 | 24 | 17 | 82 | 0.2 | 67 | 160 | 140 | 7.6 | 53 | 0.6 | 14 | 29 | 175 | |
| -1.7 | 0.1 | 14 | 22 | -16 | 6.6 | 2.0 | -2.0 | 1.5 | 53 | -41 | 5.3 | 13 | -14 | 6.8 | -33 | 19 | 20 | |
| -4.2 | -3.5 | -5.2 | -25 | -21 | -18 | -15 | -19 | -35 | 1.0 | -65 | -86 | -65 | -96 | -85 | 22 | -51 | -41 |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.